CAS: 1507367-00-1

NCL 00017509 is a small molecule drug that is being developed as an anticancer agent. The compound has shown growth-inhibitory activity in tumour cell lines and has been shown to bind to specific DNA sequences. This drug also synergizes with other cancer drugs, such as cisplatin, to produce more effective treatments. NCL 00017509 has been shown to inhibit the proliferation of various types of human cancer cells, including colon cancer cells and prostate cancer cells. It prevents the expression of proteins that cause uncontrolled cell division by binding irreversibly to dna at specific sites. NCL 00017509 is currently being investigated for its ability to suppress the growth of non-small cell lung cancers and some types of breast cancers.

Nek2-IN-5

Nek2-IN-5 (NCL00017509) is a potent and selective inhibitor of NIMA-related kinase 2 (Nek2).